Process control in the pharmaceutical industry means controlling quality during production, not after. In high shear wet granulation, this is done by detecting the correct endpoint using real-time signals.
This article explains how endpoint detection works, what to monitor during granulation, and how process analytical technology (PAT) supports better decisions. You will also learn how automation, containment, and integrated systems improve consistency, safety, and traceability.
High shear wet granulation converts powder into granules that flow better and compress into tablets more easily. The goal is to achieve consistent size, density, and moisture.
Stopping at the right point is critical.
If the process stops too early, granules remain weak.
If it runs too long, overwetting can cause lumps and poor drying.
Good control helps you:
This is where pharmaceutical process control becomes essential.
A high shear granulator mixes powders in a closed system. A binder liquid is added while mechanical energy is applied.
The process moves through clear stages:
Each stage affects final product quality.
Most systems include:
The spray system plays a key role. Uniform spray improves particle size control and reduces overwetting or unwanted agglomeration.
End point detection identifies the moment when granules meet target conditions for downstream processing.
This includes the right balance of:
Time-based control cannot adjust for raw material variation. That is why process monitoring is widely used today.
Modern systems rely on measurable signals to track granulation behavior.
Mechanical signals respond quickly to process changes:
These signals are widely used for endpoint detection.
Other useful parameters include:
These factors influence binder behavior and granule formation. Combining multiple signals improves accuracy and reduces false decisions.
Process analytical technology (PAT) provides tools to measure and control processes during production.
PAT connects real-time process monitoring with control strategies. Instead of reacting after testing, operators can adjust during production.
Closed-loop control allows the system to respond automatically based on real-time data.
A typical system will:
This approach improves consistency across batches.
Modern equipment supports:
These features reduce operator variability and improve repeatability.
The goal is to build quality into the process rather than inspect it later.
This approach aligns with:
Manufacturers define:
This framework supports consistent production and regulatory compliance.
Many pharmaceutical processes involve highly active ingredients. These require a strong containment design.
Containment systems help:
Typical solutions include:
High containment capability is essential for modern manufacturing, especially when working with potent compounds.
Modern production lines aim to reduce complexity and improve efficiency.
An integrated system connects:
This reduces manual transfer and improves process flow.
Multi-function systems help:
They also support automation integration and smart manufacturing systems.
Choosing the right approach depends on your process and product.
Key factors include:
A strong system aligns tools, data, and procedures to maintain control throughout production.
End-point control makes high shear wet granulation more predictable and easier to manage. By combining in-line signals, PAT tools, and automation, manufacturers can improve consistency and reduce risk.
If you are planning to upgrade your production, consider exploring Canaan’s integrated solutions. Our collection of granulation and OSD equipment supports real-time monitoring, automatic control, and full data traceability—helping you move toward smarter pharmaceutical manufacturing.
You monitor signals such as torque or power. When they reach a defined range linked to product quality, the process stops.
PAT is a system that measures and controls manufacturing processes using real-time data to improve product quality.
It allows operators to detect changes early and adjust the process before quality issues occur.
Quick Answer Choosing the right bin lifter for pharmaceutical manufacturing depends on facility layout and production needs. Fixed lifters suit high-volume, dedicated lines with high ceilings and capacities up to 3,000 kg, while movable lifters offer flexibility for multi-room, multi-product facilities with lower capacity limits. Evaluate space, clearance, and cGMP compliance to optimize process flow. […]
Choosing IBC bins is dependent on factors like flow characteristics of materials, contamination control considerations, cleaning techniques, and available room in facilities. In the case of the pharmaceutical manufacturing process, square bins are utilized in solid-dose products as they provide maximum volume and space-saving. Round IBC bins are often preferred for free-flowing powders, aseptic production, […]
Pharmaceutical facilities require specific intermediate bulk containers to isolate products between manufacturing steps. Using a powder container for compressed solid doses causes structural friction, causing micro-cracks and capping. Hence, proper selection directly affects your final yield, downstream quality, and strict regulatory compliance metrics. Correct vessel geometry preserves structural integrity and isolates material fields from external […]
+86-577-67378828
canaan@chinacanaan.com